Search results for “Retinal Artery Occlusion” companies
Free sign up to view the full data
Key Players
Order by:
Innovation Intensity
With the analysis among 79 patents, we discovered top 27 key players by total patent application. Aliophtha AG, Astellas Pharma, Inc., Santen Pharmaceutical Co., Ltd. are dominant in this area. They take 40.51% of the total patent filing.
Aliophtha AG
Basel-Stadt, Switzerland
Patent: 13
Astellas Pharma, Inc.
Tokyo-to, Japan
Patent: 10
Santen Pharmaceutical Co., Ltd.
Osaka-fu, Japan
Patent: 9
Toyama Chemical Co., Ltd.
Tokyo-to, Japan
Patent: 8
Daiichi Sankyo Co., Ltd.
New Jersey, United States
Patent: 7
Vascular Control Systems, Inc.
California, United States
Patent: 5
Senju Pharmaceutical Beijing Co. Ltd.
Beijing Shi, China
Patent: 5
Sankyo Co., Ltd.
Tokyo-to, Japan
Patent: 2
Amarantus Bioscience Holdings, Inc.
California, United States
Patent: 2
Aragon Surgical, Inc.
California, United States
Patent: 2
Startups & Unicorns
Order by:
Innovation Intensity
No data, please try another search term
Fast-Growing
Order by:
Innovation in recent 5 years
With the analysis among related 30 patents applied in the last 5 years. We discover 10 most active companies in this area. The fast-growing Duke University, Astellas Pharma, Inc., Kyoto University take 103.33% of patent filing during this period.
Duke University
North Carolina, United States
Patent: 12
Astellas Pharma, Inc.
Tokyo-to, Japan
Patent: 10
Kyoto University
Kyoto-fu, Japan
Patent: 9
Peking University People's Hospital
China
Patent: 1
Chengdu Kanghong Pharmaceutical Group Co., Ltd.
Sichuan Sheng, China
Patent: 1
Beijing Antin Pharmaceutical Biotechnology Co., Ltd.
Beijing Shi, China
Patent: 1
Suzhou Voxel Information Technology Co., Ltd
Jiangsu Sheng, China
Patent: 1
Lunan Pharmaceutical Group Co., Ltd.
Shandong Sheng, China
Patent: 1
GlaxoSmithKline Intellectual Property (No. 2) Ltd.
United Kingdom
Patent: 1
Yiwei Technology (Beijing) Co., Ltd.
Beijing Shi, China
Patent: 1
New Entrants
Order by:
Innovation in recent 5 years
With the analysis among related 30 patents in last 5 years, we discover 9 new entrants. Duke University, Astellas Pharma, Inc., Peking University People's Hospital are the most active new entrants in this area.
Duke University
North Carolina, United States
Patent: 12
Astellas Pharma, Inc.
Tokyo-to, Japan
Patent: 10
Peking University People's Hospital
China
Patent: 1
Chengdu Kanghong Pharmaceutical Group Co., Ltd.
Sichuan Sheng, China
Patent: 1
Beijing Antin Pharmaceutical Biotechnology Co., Ltd.
Beijing Shi, China
Patent: 1
Suzhou Voxel Information Technology Co., Ltd
Jiangsu Sheng, China
Patent: 1
Lunan Pharmaceutical Group Co., Ltd.
Shandong Sheng, China
Patent: 1
GlaxoSmithKline Intellectual Property (No. 2) Ltd.
United Kingdom
Patent: 1
Yiwei Technology (Beijing) Co., Ltd.
Beijing Shi, China
Patent: 1
Research Institutions
Order by:
Innovation Intensity
With the analysis among 29 patents, we discovered top 4 universities and scientific research institutions by total patent application. Duke University, Kyoto University, The Trustees of Columbia University in The City of New York are dominant in this area. They take 106.90% of the total patent filing.
Duke University
North Carolina, United States
Patent: 12
Kyoto University
Kyoto-fu, Japan
Patent: 10
The Trustees of Columbia University in The City of New York
New York, United States
Patent: 1
The Second Military Medical University
Shanghai Shi, China
Patent: 1
Keywords Quick Entry
Popular
Physics
Chemistry
Engineering
Materials science
Computer science
Biology
Medicine
MetalElectrodeVoltageSemiconductorPolymerElectricityCoatingFiberDisplay deviceRaw materialElectric motorUltimate tensile strengthNozzleCarbonBuilding constructionAlkylService lifeElectronOxideOxygenSolventControl unitFlangeControl systemDrugLight sourcePistonDiseaseElectric powerHigh pressure
View more
Page generation time: